SD Biotechnologies Co., Ltd. (KOSDAQ:A217480) announced a private placement of series 2 non-guaranteed private equity convertible bonds with bearer type interest part for a gross proceeds of KRW 17,000,000,000 on June 16, 2021. The transaction will include participation from Orion Luxury KOSDAQ Venture Specialized Investment Criminal Investment Trust No. for KRW 1,000,000,000, Orion Mezzanine KOSDAQ Venture Specialized Investment Criminal Equity Trust No. 57 for KRW 1,000,000,000, Orion New Deal Stepping Stone Specialized Investment Criminal Equity Fund No. 1 for KRW 1,000,000,000, Suseong KOSDAQ Venture B2 Specialized Investment Criminal Equity for KRW 1,000,000,000, Suseong KOSDAQ Venture B3 Specialized Investment Criminal Capital Investment Trust for KRW 1,000,000,000, Suseong KOSDAQ Venture B5 Specialized Investment Criminal Capital Investment Trust Main for KRW 1,000,000,000, Focus Public Offering Plus Specialized Private Equity Investment Trust No. 1 for KRW 100,000,000, Focus Mezzanine Alpha Specialized Investment Criminal Investment Trust No. 1 for KRW 300,000,000, Focus Glory Mezzanine Specialized Investment Criminal Fund No. 1 for KRW 200,000,000, Focus SY Fortress KOSDAQ Venture Specialized Investment Criminal Investment Trust No. 1 for KRW 500,000,000, Focus HERO KOSDAQ Venture Specialized Private Equity Fund No. 1 for KRW 400,000,000, Focus New Deal Plus Specialized Investment Private Equity Fund No. 1 for KRW 2,000,000,000, Fine Value Growth New Deal POST IPO4 Specialized Investment Private Equity Trust for KRW 2,000,000,000, Fine Value IPO No.2 Specialized Investment Criminal Investment Trust for KRW 1,000,000,000, New Growth One No. 2 New Technology Fund for KRW 2,500,000,000, BNK Securities Co., Ltd. for KRW 2,000,000,000. The bonds will bear be zero coupon bonds and will mature on June 18, 2026. The bonds will be 100% converted into 3,774,422 common shares at a fixed conversion price of KRW 4,504 per share for an equity stake of 14.41%. The conversion period is from June 18, 2022 to May 18, 2026. The payment date of the transaction is June 18, 2021. The securities issued in the transaction are subject to a lock up period of one year. The transaction has been approved by the board of directors of the company.